Acute Stress
Acute stress testing shows how your body activates its alarm systems. We track cortisol to gauge HPA-axis reactivity and glucose to capture rapid metabolic shifts (glycemic response). At Superpower, we test Cortisol and Glucose for Acute Stress to reveal resilience, load, and recovery capacity in real time.
Alcohol Use Disorder
Biomarker testing helps detect and quantify alcohol’s impact on liver and blood health. Elevated enzymes indicate hepatic stress and fibrosis risk; enlarged red cells reflect marrow and nutritional effects. At Superpower, we test GGT, AST/ALT, and MCV to assess Alcohol Use Disorder physiology and track recovery.
Allergic Rhinitis
Biomarker testing clarifies the immune activity behind allergic rhinitis. At Superpower, we measure Eosinophils to detect allergic, Th2-driven inflammation (eosinophilia) and CRP to gauge systemic inflammatory load (C-reactive protein). Together, these markers help characterize airway mucosal inflammation and distinguish allergic patterns from broader inflammatory responses.
Alzheimer’s Disease
Biomarker testing clarifies brain and vascular health long before symptoms appear, guiding risk recognition for Alzheimer’s disease. At Superpower, we measure homocysteine, vitamin B12, folate, and a lipid profile—markers linked to neuroinflammation, methylation, and cerebrovascular integrity—to illuminate pathways that influence amyloid and tau biology.
Asthma
Biomarker testing clarifies airway inflammation patterns in asthma, distinguishing eosinophilic activity and systemic inflammatory burden. This helps explain symptom variability and risk. At Superpower, we test for Eosinophils and CRP for asthma.
Atopic Dermatitis
Biomarker testing clarifies the inflammatory drivers of atopic dermatitis, distinguishing allergic immune activity from systemic inflammation. Elevated eosinophils reflect Th2-driven allergy; CRP tracks overall inflammatory burden. At Superpower, we test eosinophils and C‑reactive protein (CRP) to map disease activity and guide personalized understanding.
COPD
Biomarker testing clarifies COPD’s systemic burden—tracking inflammation, immune activity, and nutritional reserve that influence lung resilience. At Superpower, we measure WBC and Neutrophils (innate immune activation), CRP (acute-phase inflammation), and Albumin (protein status/negative acute-phase reactant) to contextualize airway disease within whole-body physiology.
GI Bleed
Biomarker testing flags hidden gastrointestinal bleeding by revealing iron-loss anemia. Hemoglobin tracks oxygen delivery. Iron and Ferritin quantify circulating iron and body stores. TIBC shows binding capacity and depletion patterns. At Superpower, we test Hemoglobin, Iron, Ferritin, and TIBC to detect chronic occult blood loss early.
Gallstones
Gallstones can block bile flow, stressing the liver and bile ducts. Biomarker testing tracks this cholestasis. At Superpower, we test ALP, GGT, and Bilirubin Direct for Gallstones to detect bile duct obstruction and hepatobiliary injury (cholestatic pattern) early.
IBD
IBD biomarker testing clarifies real-time inflammation and protein balance, offering objective insight beyond symptoms. At Superpower, we test CRP, ESR, and Albumin, plus composite ratios—FAR (fibrinogen-to-albumin) and CAR (CRP-to-albumin)—to gauge disease activity, systemic burden, and resilience of the gut–liver–immune axis.
NAFLD
Early biomarker testing for NAFLD reveals silent liver stress and metabolic strain, before symptoms. It tracks hepatocellular injury and cholestasis, and atherogenic lipid load. At Superpower, we test ALT, AST, GGT, Triglycerides, HDL, LDL, ApoB, and AIP to map liver-metabolic interplay and NAFLD risk.
Pancreatitis
Pancreatitis reflects disrupted digestive enzyme control and inflammatory injury in the pancreas. Biomarker testing clarifies root causes and risk. At Superpower, we measure Triglycerides and Calcium, detecting hypertriglyceridemia and hypercalcemia, key metabolic drivers that can precipitate pancreatic inflammation and predict severity (lipotoxicity, calcium-mediated trypsin activation).
Peptic Ulcer Disease
Peptic ulcer disease can bleed slowly, depleting iron and lowering red blood cell capacity before symptoms are obvious. Biomarker testing detects this hidden impact on oxygen delivery and iron stores. At Superpower, we test Hemoglobin (Hb), Iron, and Ferritin to identify anemia and iron deficiency from occult gastrointestinal bleeding.
Sleep Apnea
Sleep apnea strains the heart, blood vessels, and metabolism. Biomarker testing uncovers hidden stress—chronic inflammation, atherogenic lipids, high blood sugar, and insulin resistance—clarifying burden and risk. At Superpower, we test for hs-CRP, Lipids, Glucose, and Insulin for Sleep Apnea to map physiology and track change.
